Marcella Caro, APRN
Family · St Petersburg, FLNPI 1124529094
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $292 of the $372 with a category attached, or 78.5%. 5 manufacturers reported payments, led by UCB, Inc. at 33.3% of the total. Reporting peaked in 2023 at $141 and has fallen 76.2% since, to $33 in 2025. That places this record below the midpoint for family clinicians in FL, where the typical reported total is $350.
Across 11 payments — averaging $33.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$124
- AbbVie$97
- Seagen Inc.$80
- Novo Nordisk$38
- Stryker$33
What the payments were for
- Food & beverage$29279%
- Education$8021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 2 | $124 |
| AbbVie | 5 | $97 |
| Seagen Inc. | 1 | $80 |
| Novo Nordisk | 2 | $38 |
| Stryker | 1 | $33 |
How this compares
$372 in reported general payments places this provider in the 50th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 28 | $4,690 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $1,064 |
| Gabapentin | 23 | $516 |
| Amlodipine Besylate | 30 | $509 |
| Atorvastatin Calcium | 45 | $358 |
| Olanzapine | 17 | $274 |
| Famotidine | 21 | $271 |
| Pregabalin | 16 | $175 |
| Lisinopril | 24 | $166 |
| Trazodone Hcl | 19 | $130 |
| Metoprolol Tartrate | 18 | $130 |
| Citalopram HbrCitalopram Hydrobromide | 13 | $85 |
| Simvastatin | 16 | $76 |
| Furosemide | 11 | $68 |
| Prednisone | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Other family in St Petersburg
- Terry LawSt Petersburg$33K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.